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Effect of renal transplantation in childhood on longitudinal
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Background. Severe growth failure is frequently observed in
children suffering from end-stage renal disease (ESRD).
Methods. We analyzed the effect of renal transplantation
(RTx) on longitudinal growth and final height in 37 children
(19 girls) with ESRD with a mean follow-up of 8.5 years. The
mean age at RTx was 11.3 years.
Results. In children transplanted before start of puberty,
mean height velocity increased significantly from 4.9 to 8.0 cm/
year (P < 0.01), resulting in an increase in standardized height
of 0.6 SD within two years post RTx. Although peak height
velocity during puberty was significantly increased compared
with healthy children, total pubertal height gain was reduced
by 20% because of its shortened duration. Mean standardized
height significantly increased from the time of RTx until final
height by 1.3 SD and 0.7 SD in children transplanted before
and after start of puberty, respectively. Mean adult height (boys
170 cm; girls 151 cm) was normal (>−2 SD) in 68% of patients.
Change in standardized height from RTx until adult height was
associated with initial degree of stunting and glomerular filtra-
tion rate (GFR; cumulative r2 0.49). Total pubertal height gain
was associated with the age at start of puberty, GFR, and age at
RTx (cumulative r2 0.57).
Conclusion. RTx in children with ESRD induces moderate
catch-up growth during the prepubertal growth period. How-
ever, final height is reduced in about one third of patients due to
the reduced pubertal height gain and preexisting height deficit
at the time of RTx.
Children suffering from chronic renal failure (CRF)
are prone to develop severe growth failure. Therefore,
a normal final adult height is one of the cardinal goals
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for rehabilitation of children suffering from end-stage re-
nal disease (ESRD). Previous reports have shown that
about 50% of children reaching ESRD before the age of
15 years are stunted (height below 3rd percentile) [1].
Today, it is possible to reduce this growth impairment by
aggressive treatment of the complications of uremia, es-
pecially by enhancing nutrition in early childhood, and
by treatment with recombinant human growth hormone
(rhGH) in the pretransplant state [2, 3]. Growth usually
does not improve in children on dialysis, and the over-
all results with respect to longitudinal growth have been
disappointing [4].
Renal transplantation (RTx) resolves many of the
metabolic and endocrine disorders contributing to ure-
mic growth failure, but it has been reported that catch-up
growth after RTx is rare and usually restricted to young
prepubertal children [5]. There is only limited knowledge
regarding the effect of RTx on longitudinal growth and
the resultant final adult height. All previous studies eval-
uating the effect of RTx in childhood and adolescence
have suffered from several restrictions: only short-term
growth but no final height data were reported, study pop-
ulations were treated with different treatment modalities
for ESRD, and/or no assessment of the total pubertal
height gain was made [6–9]. The latter fact seems to be of
special importance because patients with ESRD usually
present with a delayed onset of puberty. Consequently,
the use of reference values for height and height veloc-
ity (i.e., height and height velocity Z-scores) of healthy
children with a normal onset of puberty may not be ap-
propriate for these children.
We therefore retrospectively analyzed the effect of
RTx on longitudinal growth and final height in 37 chil-
dren with ESRD who were observed at our institution
from the prepubertal growth period up to adult height.
By use of modern auxologic tools we were able to sep-
arately assess the effect of RTx and other contributing
factors on prepubertal and pubertal growth, respectively.
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Table 1. Anthropometric characteristics of children transplanted before and after onset of pubertal growth spurt
Boys Girls
RTx before RTx during RTx before RTx during
puberty (N = 7) puberty (N = 11) P value puberty (N = 6) puberty (N = 13) P value
Age at RTx years 9.9 ± 2.2 14.2 ± 1.4 <0.0001 6.9 ± 1.4 11.7 ± 1.7 <0.0001
Height at RTx cm 129.3 ± 8.8 148.8 ± 10.2 0.0007 103.9 ± 10.1 133.1 ± 14.0 0.0003
Height at RTx (SDS) −1.3 ± 2.1 −2.0 ± 1.3 0.39 −3.9 ± 1.1 −2.4 ± 2.4 0.17
Midparental target height cm 185.3 ± 5.9a 182.1 ± 4.3a 0.42 163.0 ± 3.5b 167.2 ± 5.1c 0.13
Predicted adult height at RTx cm 173.2 ± 11.7 173.8 ± 8.4 0.90 152.8 ± 4.9 153.8 ± 15.4 0.88
Age at start of pubertal growth spurt yearsd 13.1 ± 1.7 12.8 ± 1.7 0.72 10.6 ± 1.6 10.6 ± 1.5 0.99
Duration of pubertal growth spurt yearse 4.2 ± 0.6 5.0 ± 2.0 0.32 4.1 ± 1.2 5.1 ± 1.1 0.09
Total pubertal height gain cmf 24.4 ± 4.8 26.3 ± 2.5 0.71 22.2 ± 7.5 24.9 ± 6.8 0.45
Total pubertal height gain (SDS) −1.2 ± 0.7 −0.9 ± 1.7 0.67 −0.6 ± 0.8 −0.4 ± 0.7 0.59
Adult height cm 172.0 ± 13.6 168.1 ± 7.0 0.43 149.1 ± 5.4 152.3 ± 9.5 0.46
Adult height (SDS) −0.6 ± 2.1 −1.3 ± 1.0 0.35 −2.0 ± 1.2 −1.8 ± 1.7 0.80
Values are mean (± SD). P value denotes differences between children transplanted before or after onset of pubertal growth spurt.
aN = 4; bN = 5; cN = 8; dvalues for normal children: boys, 10.9 ± 1.0 years; girls, 9.6 ± 1.0 years; evalues for normal children: boys, 6.5 ± 1.0 years; girls, 5.9 ± 1.0
years; fvalues for normal children: boys, 32.7 ± 7.2 cm; girls, 28.7 ± 10.0 cm.
METHODS
Study subjects
Since August 1983, 191 patients under the age of
16 years received their first functioning renal allograft
at the Charite´ University Hospital, Berlin. In order to
analyze the effect of RTx on pubertal growth, the anal-
ysis presented here was restricted to those 37 children
(18 boys, 19 girls) who had complete growth data (3- to
6-month intervals) starting at least one year before on-
set of pubertal growth spurt, and who reached their final
adult height by January 2002, as defined by a height veloc-
ity below 1 cm per year (Table 1). Children not arriving
at final height (N = 24), those with incompletely data
(N = 97), those with renal allografts that ceased to func-
tion within one year after RTx (N = 29), and those re-
ceiving rhGH (N = 2) or androgen therapy (N = 2) after
RTx were excluded from the analysis. None of the pa-
tients received rhGH treatment before RTx.
All children were born between December 1971 and
November 1985. Thirteen children were transplanted be-
fore and 24 after onset of puberty. Mean age at first ob-
servation was 6.2 ± 2.1 years and 8.9 ± 2.4 years (P <
0.0017), mean standardized height was –2.0 ± 2.4 SD
and –1.5 ± 1.8 SD (P = 0.48), duration of CRF (i.e.,
time since diagnosis of CRF) was 3.4 ± 3.0 years and
6.5 ± 1.3 years at the time of RTx (P < 0.0001), and
the time on dialysis was 1.2 ± 0.7 years and 1.7 ±
1.3 years (P = 0.20), respectively, in children transplanted
before and during puberty. The percentage of children
transplanted before onset of puberty (during puberty)
suffering from obstructive or reflux uropathy, renal dys-
plasia, or hypoplasia was 31% (50%), congenital and
hereditary nephropathies was 15% (13%), glomerular
diseases was 46% (29%), and nephropathic cystinosis
was 8% (8%) (P > 0.05 each). At the time of first ob-
servation 27 children were receiving conservative treat-
ment, and 10 were on dialysis (2 on peritoneal dialysis, 8
on hemodialysis). At the time of RTx all children were
receiving dialysis (10 peritoneal dialysis, 27 hemodialy-
sis). Dialysis was reinstituted during the study period in
2 children, both of whom subsequently received a second
renal allograft. All except one patient (second RTx) had
received their first renal allograft; 31 patients received ca-
daveric grafts, and 6 patients received living related grafts.
The median follow-up time from first observation to final
height was 8.5 years (range 2.8 to 16.6). The median time
with a functioning renal allograft was 5.2 years (range 1.1
to 11.7). The mean glomerular filtration rate (GFR) after
RTx until attainment of final height amounted to 55 mL/
min/1.73m2 (range 8 to 95) and to 58 mL/min/1.73m2
(range 16 to 106) in patients transplanted before and after
onset of puberty, respectively. During the study period of
18 years, immunosuppressive protocols changed. Nine-
teen patients received cyclosporine A and prednisolone,
14 patients received cyclosporine A, prednisolone, and
either azathioprine (N = 12) or mycophenolate mofetil
(N = 2), and 4 patients received azathioprine and pred-
nisolone. Prednisolone was administered daily in all pa-
tients, but was weaned off during the follow-up in 4 out of
37 patients after a mean period of 4.5 years (range 2.9 to
7.7). Mean dosage after RTx amounted to 3.6 mg/m2/day
(range 1.2 to 11.2). Acute rejection episodes (N = 43)
were treated with four intravenous pulses of methylpred-
nisolone (400, 200, 200, 100 mg/m2/day). Steroid-resistant
rejection was treated with either antithymocyte globulin
(Merrieux, France) or tacrolimus.
Clinical studies
Evaluation concerned data from the time of first ob-
servation up to attainment of final height. At each ex-
amination the following items were recorded: height,
sexual maturation, serum creatinine, treatment modality
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of renal failure (conservative treatment, peritoneal dial-
ysis, hemodialysis, RTx), type and dose of immunosup-
pressive drugs, occurrence of acute or chronic rejec-
tion episodes (diagnosed by renal biopsy or increased
serum creatinine), and bone age if appropriate. Bone age
was determined according to the Tanner-Whitehouse-2
method [10]. Reference data for growth analysis were
taken from the Zurich Longitudinal Growth Study [11].
Where parental heights were available, genetic target
height was calculated as mid-parental height +10 cm for
boys and −2.6 cm for girls [12]. The method of Molinari
et al was chosen because it takes into account the secu-
lar trend. Predicted adult height was calculated using the
Tanner method [10]. GFR was estimated by the cal-
culated creatinine clearance [13]. In patients on dialy-
sis treatment, creatinine clearance was approximated to
7 mL/min/1.73m2.
Analysis of growth and statistical analyses
To minimize the influence of measurement errors,
height data were smoothed by kernel estimation, a math-
ematical procedure applying moving weighted averages
to raw data [14, 15]. From the smoothed growth curve, the
corresponding height velocity curve was calculated as the
first derivative of height by time. In children transplanted
before puberty, the point at which the height velocity
curve reached a first maximum after RTx was defined as
the RTx-induced peak height velocity. The time of max-
imal height velocity during puberty defined the pubertal
peak height velocity, and the proceeding nadir the mini-
mal prespurt height velocity, the starting point of the pu-
bertal growth spurt [14]. The end of the pubertal growth
spurt was defined as the age at which the late height veloc-
ity curve permanently declined below 1 cm/year. In chil-
dren transplanted after start of the pubertal growth spurt,
no discrimination between RTx and puberty-induced in-
crease in height velocity was possible. Therefore, total
pubertal height gain (i.e., height gain from the time of
minimal prespurt height velocity until end of pubertal
growth spurt), was calculated. To obtain a ‘structural aver-
age growth curve’ the individual smoothed growth curves
were synchronized using five ‘nodes:’ the time of first ob-
servation, the peak height velocity after RTx in children
transplanted before puberty, minimal prespurt height ve-
locity, pubertal peak height velocity, and the end of the
pubertal growth spurt [3, 7]. For this purpose, a synchro-
nization program was applied which transforms the time
scale of each individual curve to align the characteristic
points with their respective means [16].
Results are expressed as mean ± SD. Comparisons be-
tween groups were performed by analysis of variance
(ANOVA), followed by Duncan’s multiple-range test.
The longitudinal changes in anthropometrics measure-
ments were evaluated by repeated-measure ANOVA,
including a within-subject factor (time) and a between-
subject factor (RTx before puberty vs. RTx after on-
set of pubertal growth spurt). Pair-wise comparisons be-
tween different time points were performed using the
CONTRAST option of the general linear models proce-
dure in the SAS/STAT software (Cary, NC, USA).
Univariate linear regression analysis was performed
to identify possible predictors of the degree of catch-up
growth (i.e., change in standardized height during the first
two years post RTx in patients transplanted before pu-
berty), change in standardized height from the time of
RTx until final height, and total pubertal height gain. The
following variables were examined: age, bone age, bone
age retardation, height SDS, target height deficit (i.e.,
height SDS minus target height SDS) at baseline, dura-
tion of CRF and time on dialysis before RTx, GFR (i.e.,
mean GFR during the corresponding time period), sex,
age at start of the pubertal growth spurt, prednisolone
dosage in transplanted patients, underlying renal dis-
ease, living or cadaveric graft, and number of rejection
episodes and steroid pulses. Multiple regression analysis
was performed starting with a model including all poten-
tial predictors (see above), followed by stepwise elimina-
tion of those variables that did not significantly contribute
to the overall variance of the model. All P values are
two-sided.
RESULTS
Prepubertal growth
The synchronized mean height velocity curves for the
children transplanted before start of pubertal growth
spurt compared with normal children are shown in
Figure 1. During the prepubertal observation period the
height velocity in boys and girls was significantly in-
creased after RTx as compared with baseline, exceed-
ing the values in normal children (each P < 0.001). The
mean height velocity in the transplanted boys and girls
increased from 4.4 and 5.6 cm/year to a maximum of 6.4
and 9.3 cm/year, respectively (boys P < 0.002; girls P <
0.01). After this prepubertal peak, height velocity con-
tinuously decreased until the start of the pubertal growth
spurt.
In both boys and girls mean standardized height de-
creased from the time of first observation until RTx by
0.6 SD and 0.5 SD, respectively (boys P = 0.087; girls
P < 0.05). After RTx, mean standardized height was in-
creased within two years by 0.6 SD (P < 0.01). Due to the
markedly delayed onset of puberty in the transplanted
children, mean standardized height at the time of start of
the pubertal growth spurt was not significantly different
in boys at the time of RTx (+0.1 SD; range –0.8 to 1.8;
P = 0.69), but was significantly higher in girls after RTx
(+1.3 SD; range –0.5 to 2.8; P < 0.05).
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Fig. 1. Synchronized mean height velocity
curves (left panels) and synchronized mean
growth curves (right panels) of boys (upper
panels) and girls (lower panels) transplanted
before onset of puberty, as compared with
normal children. Abbreviations are: RTx, re-
nal transplantation; MHV, minimal prespurt
height velocity; PHV, peak height velocity;
EHV, end-point height velocity.
Pubertal growth
The mean peak height velocity during the pubertal
growth spurt was significantly higher in children trans-
planted before puberty (boys 9.0 cm/year; girls 8.3 cm/
year) or during puberty (boys 9.3 cm/year; girls 8.9 cm/
year) compared to healthy children (boys 7.8 cm/year;
girls 6.5 cm/year; each P < 0.001) (Figs. 1 and 2). The
onset of the pubertal growth spurt was delayed in the
transplanted children by approximately 1.5 years, and its
duration was shortened compared to normal children by
1.6 years (children transplanted before and after onset of
puberty vs. normal children, each P < 0.01). In both chil-
dren transplanted before and after onset of puberty, the
onset of the pubertal growth spurt was more delayed in
boys than in girls (each P < 0.03, Table 1). The duration
of the pubertal growth spurt tended to be shorter in boys
than in girls, as well as in children transplanted before
puberty compared to those transplanted during puberty
(each P > 0.05; Table 1).
Total pubertal height gain in the transplanted patients
was significantly reduced, amounting to 79% of normal,
due to the shortened duration of the pubertal growth
spurt, and tended to be more reduced in boys than in
girls, irrespective of the time of RTx (Table 1). The total
pubertal height gain did not significantly differ between
children transplanted before and after onset of puberty
(each P > 0.05).
Predicted and actual adult height
The boys and girls transplanted before puberty reached
adult height at a mean age of 17.3 and 14.7 years, respec-
tively. Standardized height increased significantly after
RTx by a mean of 1.3 SD (boys +0.8; girls +1.9) to a
mean final height of −1.2 ± 1.8 SD (P < 0.02 vs. baseline;
Table 1). Sixty-nine percent of these children reached an
adult height within the normal range (>−2 SD). How-
ever, mean adult height was lower than midparental tar-
get height by 5.2 cm in boys and 13.0 cm in girls, respec-
tively (each P < 0.05; Table 1).
In the boys and girls transplanted after onset of pu-
berty, adult height was reached at a mean chronologic
age of 17.8 and 15.7 years, respectively. Although mean
final height was higher compared to the time at RTx by
0.8 SD in boys (P < 0.05) and by 0.6 SD in girls (P =
0.08), respectively, final height was markedly below mid-
parental target height (boys −12.6 cm; girls −12.6 cm;
each P < 0.01). Adult height was within the normal range
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Fig. 2. Synchronized mean height velocity
curves (left panels) and synchronized mean
growth curves (right panels) of boys (upper
panels) and girls (lower panels) transplanted
after onset of puberty, as compared with nor-
mal children. Abbreviations are: RTx, re-
nal transplantation; MHV, minimal prespurt
height velocity; PHV, peak height velocity;
EHV, end-point height velocity.
(>−2 SD) in 67%, and above the normal mean (>0 SD)
in 22% of the patients.
In boys and girls transplanted before puberty, mean fi-
nal height was slightly overpredicted at the time of trans-
plantation, and markedly overpredicted at the time of
start of pubertal growth spurt by approximately 2.4 cm
(P = 0.28) and 6.4 cm (P < 0.05), respectively (Fig. 3). In
children transplanted after onset of puberty, mean final
height was overpredicted at the time of start of pubertal
growth spurt and at the time of RTx by approximately
7.0 cm (P < 0.05) and 4.0 cm (P = 0.06), respectively.
Growth predictors
In patients transplanted before puberty, prepubertal
catch-up growth (i.e., change in standardized height dur-
ing the first two post-transplant years), as well as total
pubertal height gain was negatively correlated with age
at RTx, and positively correlated with GFR, explaining
altogether 63% up to 77% of the total variability (Figs. 4
and 5; Table 2). Prednisolone dosage tended to be neg-
atively correlated with prepubertal and pubertal growth
(Figs. 4 and 5).
In the whole study population, the height gain from the
time of RTx until final height was positively correlated
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with the degree of stunting at RTx and GFR (Table 2).
Total pubertal height gain was significantly correlated
with age at start of puberty (negative), GFR (positive),
and age at RTx (negative). Gender, underlying renal dis-
ease, mode of RTx (cadaveric vs. living related), bone
age retardation at the time of RTx, duration of CRF and
time on dialysis before RTx, number of rejection episodes
and steroid pulses did not significantly influence post-
transplant growth.
DISCUSSION
This is the first study analyzing the effect of RTx on
the prepubertal and pubertal growth period separately.
Children transplanted before puberty showed continu-
ous catch-up growth during the prepubertal growth pe-
riod. Although peak height velocity during puberty was
significantly increased compared to healthy children, to-
tal pubertal height gain was reduced by approximately
20% because of its shortened duration. However, mean
standardized height significantly increased from the time
of RTx until final height by 1.3 SD and 0.6 SD in chil-
dren transplanted before and after start of puberty, re-
spectively. Sixty-eight percent of the patients reached a
normal adult height. Age and degree of stunting at the
time of RTx, age at start of puberty, and GFR were sig-
nificant predictors of prepubertal and pubertal growth,
explaining altogether between 49% and 77% of the over-
all variability.
Prepubertal growth
Prepubertal catch-up growth after RTx has been re-
ported in some [5, 17, 18] but not all [9] previous stud-
ies. Whereas a previous analysis suggested that catch-up
growth after RTx is restricted to children under the age
of 6 years [5], a significant increase in standardized height
was observed in the present study, even in children up to
9 years of age at the time of RTx. The height velocity after
RTx during the prepubertal growth period significantly
exceeded that of healthy children, resulting in a mean
increase in standardized height of +0.6 SD within two
years. However, standardized height at the start of the
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Table 2. Multiple linear regression analysis of predictors of growth
during observation period
Predictor Effect Partial R2
Patients transplanted prior to puberty
Height gain during
first two yrs after
RTx (SDS)
Age at RTx years Negative 0.59
Mean GFR 2 y after
RTx mL/min/1.73m2
Positive 0.18
0.77a
Total pubertal height
gain (SDS)
Age at RTx years Negative 0.51
Mean GFR after RTx
mL/min/1.73m2
Positive 0.12
0.63a
Whole study population
Height gain after
RTx until adult
height (SDS)
Height at RTx (SDS) Negative 0.38
Mean GFR after RTx
mL/min/1.73m2
Positive 0.11
0.49a
Total pubertal height
gain (SDS)
Age at start of puberty
years
Negative 0.41
Mean GFR after RTx
mL/min/1.73m2
Positive 0.05
Age at RTx years Negative 0.03
0.57a
aCumulative R2.
pubertal growth spurt was only slightly increased com-
pared to baseline. This was probably due to the marked
delay of the onset of the pubertal growth spurt by about
1.5 years in the transplanted children. In other words,
comparing growth data of prepubertal RTx patients to
that of normal children already exhibiting a pubertal
growth spurt may have led to an underestimation of their
longitudinal growth.
Age at RTx and GFR were strong predictors of prepu-
bertal catch-up growth, explaining together 77% of the
overall variability. None of the patients above 9 years of
age or with a GFR less than 50 mL/min/1.73m2 showed
a positive change in standardized height during the first
two post-transplant years. This finding is in line with pre-
vious studies showing a significant correlation between
post-transplant growth and age and GFR during the pre-
pubertal growth period [18, 19]. Interestingly, the peak
height velocity after RTx was significantly higher in girls
compared to boys. However, multiple regression anal-
ysis did not reveal any sex differences with respect to
growth after RTx, pointing out that the higher peak height
velocity in girls was probably due to their younger age
(Table 1).
Surprisingly, the prednisolone dosage was not sig-
nificantly associated with prepubertal post-transplant
growth. In contrast, several previous studies could clearly
demonstrate a negative effect of corticosteroid treatment
on post-transplant growth (i.e., total steroid avoidance
or alternate day treatment was associated with a signifi-
cantly better growth compared to daily low dose steroid
treatment) [17, 20, 21]. We assume that the lack of corre-
lation between post-transplant growth and prednisolone
dosage observed in the present study was due to the fact
that prednisolone was given daily in all patients, and that
there was only a small dosage range (i.e., 2 up to 6 mg/m2
day) during the first two years post RTx. It has recently
been shown in prepubertal RTx patients that growth
rate was tightly associated with the time-averaged pred-
nisolone serum concentrations, whereas a rather weak
correlation was found for the given prednisolone dosages
[22]. Therefore, despite a lack of correlation between
growth rates and corticosteroid dosages in the present
study, we cannot exclude a growth-depressive effect of
corticosteroids in our patients.
In the children transplanted during puberty, the con-
tinuous decrease of height velocity in the prepubertal
period was striking (Fig. 2). Consequently, mean height
velocity at start of puberty was reduced by approximately
50% compared to healthy children. A similar decrease in
height velocity at pubertal onset has been described be-
fore in children with ESRD [3, 7]. This seems to represent
an accentuation of the physiologic phenomenon of the
‘prepubertal dip’ due to the severe delay of the pubertal
growth spurt [23].
Pubertal growth
In children transplanted before and after start of pu-
berty, the mean peak height velocity during puberty was
significantly higher compared to healthy children. How-
ever, because the onset of the pubertal growth spurt was
markedly delayed and of shorter duration, total puber-
tal height gain was reduced by approximately 20%. The
main factors influencing the cumulative pubertal height
gain were age at start of pubertal growth spurt (negative),
age at RTx (negative), and GFR (positive). These three
factors explained about 60% of the overall variability of
pubertal height gain.
Age at start of puberty was a strong negative predic-
tor of pubertal growth. Therefore, the delayed onset of
puberty in RTx patients resulted in an eventual loss of
height potential. A diminished pubertal height gain has
also been shown in other chronic diseases leading to a
delayed onset of puberty (e.g., cystic fibrosis and Crohn’s
disease) [24–26]. Therefore, this finding seems to be a
general phenomenon and not specific for RTx patients.
Interestingly, the strong negative association between
age at RTx and pubertal height gain was not only present
in the whole study population but also seen in patients
transplanted before puberty. Indeed, in the latter cohort
age at RTx alone explained already 50% of the total vari-
ability of the pubertal height gain. This novel finding sug-
gests that early transplantation in children with ESRD is
not only mandatory for optimal prepubertal growth but
also for pubertal growth. A possible explanation might be
that an early transplantation results in a shortening of the
exposure to the uremic milieu and its growth-depressing
effects.
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The third strong predictor of pubertal growth was renal
function. A GFR above 60 mL/min/1.73m2 was manda-
tory in order to achieve a pubertal height gain of more
than minus 1 SD. The present study confirms previous
short-term observations showing a negative correlation
between growth rates and GFR during puberty [8, 18].
It therefore seems that an early transplantation resulting
in a good GFR is the best prerequisite for an optimal
pubertal height gain after RTx.
Prednisolone dosage was not a significant predictor
of pubertal height gain. This finding is in contrast to
the study Schaefer et al [7], who observed a signifi-
cant negative correlation between the peak height veloc-
ity during puberty and prednsiolone dosage after RTx.
This difference might be partly explained by the higher
prednisolone dosages applied in the latter study.
Peak height velocity as well as the cumulative pubertal
height gain observed in our study was markedly higher
compared to a previous study performed in the precy-
closporine era, reporting a 50% reduction for these vari-
ables in RTx patients [7]. In addition, the delay of the
pubertal onset (1.5 vs. 2.5 years) was less pronounced in
the present study. This difference could result from longer
periods of dialysis treatment reported by Schaefer et al
[7] because height gain during puberty is severely dimin-
ished in children on dialysis treatment [1]. In addition,
because all our patients were treated in the cyclosporine
era, their cumulative steroid exposure was significantly
lower.
Although the cumulative pubertal height gain in pa-
tients transplanted during puberty was reduced, a signifi-
cant increase in standardized height from the time of RTx
up to final height was noted. This finding might be related
to the different timing of the pubertal growth spurt com-
pared to healthy children. Consequently, assessments of
longitudinal growth in the pubertal age range are lim-
ited if reference values of height and height velocity
(i.e., height and height velocity Z-score) of healthy chil-
dren showing a normal onset of puberty are used. This
might partly explain why a positive change in standard-
ized height during the pubertal age range after RTx was
irregularly observed in short-term analysis [5, 8]. How-
ever, even a positive change in standardized height dur-
ing puberty does not necessarily indicate true catch-up
growth because the only reliable parameter assessing pu-
bertal growth independently of pubertal timing is total
pubertal height gain.
Final height
Despite catch-up growth during the prepubertal
growth period, adult height was reduced in one third of
patients. The mean difference between adult height and
genetic target height was approximately 15 cm. This was
mainly due to the reduction of the pubertal height gain
and the preexisting height deficit at the time of RTx. Pre-
vious studies have suggested that the height deficit of pa-
tients with ESRD might be partially corrected by a pro-
longed pubertal growth period [27]. In fact, final height in
the present study was attained about one year later than
in healthy children. However, the pubertal growth pe-
riod was shortened by approximately 1.5 years compared
to healthy children due to its delayed onset. Although
we cannot rule out a significant height increment during
the following years after end-height velocity was reached
in some patients, a prolonged pubertal growth period in
patients after RTx was not observed in the majority of
patients.
The final height data in the present study confirms
the trend for better outcome in children transplanted
in the cyclosporine era compared to the precyclosporine
era. The median adult height after RTx in 10 previously
published single and multicenter reports amounted to
−2.2 SD (range −1.4 up to −2.5), and to −1.4 SD (range
−1.1 up to −2.3) for the precyclosporine [6, 7, 28–31] and
cyclosporine era, respectively [9, 18, 31–33]. However, a
positive change in standardized height after RTx until
final height as observed in the present study has rarely
been reported previously. The somewhat better outcome
of our patients might be attributed to better preservation
of graft function, younger age at the time of RTx, and/or
lower corticosteroid dosages.
Currently, several clinical trials are under way in order
to investigate the effect of rhGH treatment on final height
in children with persistent growth failure after RTx [34,
35]. The patients presented in our analysis have never
received rhGH treatment (neither pre- nor post-RTx).
Therefore, their growth data might be useful for evalu-
ation of the efficacy of rhGH treatment post RTx with
respect to pubertal growth and adult height.
Predicting final height
The applicability of adult height prediction methods is
a question of special interest in children suffering from
CRF. In the present study the prediction error at the time
of RTx was 3.0 cm with a general trend to overpredict
eventual height. The magnitude of overprediction was
even higher (i.e., 6 cm) at the time of the start of the pu-
bertal growth spurt. A tendency for overprediction of fi-
nal height in children with CRF has been reported before
[3, 27], and has been attributed to unpredictable changes
in treatment modalities for CRF and renal osteodystro-
phy. In addition, we could not demonstrate a significant
relationship between the degree of bone age delay at the
time of RTx or start of pubertal growth spurt with even-
tual catch-up growth, indicating that bone age retardation
seems not to be a relevant predictor for height potential
in these children. This is probably due to the previously
described dissociation between bone maturation and pu-
bertal growth in RTx patients, which has been attributed
to alterations of the somatotropic and gonadotropic
hormone axes, and growth suppressing effects of
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glucocorticoids [7, 27, 36]. Therefore, any growth poten-
tial related to delayed bone maturation is restrained dur-
ing the post transplant growth period.
CONCLUSION
RTx in children with ESRD induces moderate catch-up
growth during the prepubertal growth period. However,
final height is reduced in about one third of the patients
due to the reduced pubertal height gain and preexisting
height deficit at the time of RTx. Efforts to avoid a height
deficit before RTx, such as rhGH treatment [3], early
(preemptive) RTx, introduction of new immunosuppres-
sive strategies for optimal graft function, and possible
steroid withdrawal are necessary to improve final height
in children after RTx.
ACKNOWLEDGMENTS
We are indebted to Professor Theo Gasser (Technische Eid-
geno¨ssische Hochschule, Zurich, Switzerland) and Dr. Eva Hermann
(Technische Universita¨t, Darmstadt, Germany) for introducing us to
the auxologic tools used in the study. Richard Nissel was supported by
a grant from Pharmacia, Erlangen, Germany.
Reprint requests to Dieter Haffner, M.D., Department of Pediatric
Nephrology, Charite´ University Hospital, Augustenburger Platz 1, D –
13353 Berlin, Germany.
E-mail: dieter.haffner@charite.de
REFERENCES
1. EHRICH JH: Combined Report on Regular Dialysis and Transplan-
tation in Europe Part III: Renal Replacement Therapy in Chil-
dren. Presentation at the XXIX Congress of European Renal
Association—The European Dialysis and Transplant Association,
Paris, June 28–July 1, 1992
2. KARI JA, GONZALEZ C, LEDERMANN SE, et al: Outcome and growth
of infants with severe chronic renal failure. Kidney Int 57:1681–7,
2000
3. HAFFNER D, SCHAEFER, NISSEL R, et al: Effect of growth hormone
treatment on the adult height of children with chronic renal failure.
German Study Group for Growth Hormone Treatment in Chronic
Renal Failure. N Engl J Med 343:923–30, 2000
4. LERNER GR, WARADY BA, SULLIVAN EK, et al: Chronic dialysis
in children and adolescents. The 1996 annual report of the North
American Pediatric Renal Transplant Cooperative Study. Pediatr
Nephrol 13:404–17, 1999
5. TEJANI A, FINE R, ALEXANDER S, et al: Factors predictive of sustained
growth in children after renal transplantation. The North American
Pediatric Renal Transplant Cooperative Study. J Pediatr 122:397–
402, 1993
6. VAN DIEMEN-STEENVOORDE R, DONCKERWOLCKE RA, BRACKEL H,
et al: Growth and sexual maturation in children after kidney trans-
plantation. J Pediatr 110:351–6, 1987
7. SCHAEFER F, SEIDEL C, BINDING A, et al: Pubertal growth in chronic
renal failure. Pediatr Res 28:5–10, 1990
8. MAXWELL H, HAFFNER D, REES L: Catch-up growth occurs after
renal transplantation in children of pubertal age. J Pediatr 133:435–
440, 1998
9. RODRı´GUEZ-SORIANO J, VALLO A, QUINTELA MJ, et al: Predictors of
final adult height after renal transplantation during childhood: A
single-center study. Nephron 86:266–273, 2000
10. TANNER JM, MARSHALL WA, HEALY MJ, GOLDSTEIN H: Assessment
of Skeletal Maturity and Prediction of Adult Height (TW2 Method),
2nd ed, New York, Academic Press, 1983
11. PRADER A, LARGO RH, MOLINARI L, ISSLER C: Physical growth of
Swiss children from birth to 20 years of age. Helv Paediatr Acta
52(Suppl):1–125, 1989
12. MOLINARI L, LARGO RH, PRADER A: Target height and secular trend
in the Swiss population, in Human Growth and Development, edited
by Borms J, New York, Plenum, 1985, pp 193–200
13. SCHWARTZ GJ, BRION LP, SPITZER A: The use of plasma creatinine
concentration for estimating glomerular filtration rate in infants,
children, and adolescents. Pediatr Clin North Am 34:571–90, 1987
14. GASSER T, KO¨HLER W, MU¨LLER HG, et al: Velocity and acceleration
of height growth using kernel estimation. Ann Hum Biol 11:397–
411, 1984
15. GASSER T, KO¨HLER W, KNEIP A: A method for determining the
dynamics and intensity of average growth. Ann Hum Biol 17:459–
74, 1990
16. GASSER T: Analysing curves using kernel estimators. Pediatr
Nephrol 5:447–50, 1991
17. ELLIS D: Clinical use of tacrolimus (FK-506) in infants and children
with renal transplants. Pediatr Nephrol 9:487–494, 1995
18. FINE RN, HO M, TEJANI A: The contribution of renal transplantation
to final adult height: A report of the North American Pediatric
Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol
16:951–6, 2001
19. QVIST E, MARTTINEN E, RONNHOLM K, et al: Growth after renal trans-
plantation in infancy or early childhood. Pediatr Nephrol 17:438–43,
2002
20. BROYER M, GUEST G, GAGNADOUX MF: Growth rate in children re-
ceiving alternate day steroid treatment after kidney transplantation.
J Pediatr 120: 721–5, 1992
21. KLARE B, STROM TM, HAHN H, et al: Remarkable long-term prog-
nosis and excellent growth in kidney-transplant children under cy-
closporine monotherapy. Transplant Proc 23:1013–1017, 1991
22. SARNA S, HOPPU K, NEUVONEN PJ, et al: Methylprednisolone ex-
posure, rather than dose, predicts adrenal suppression and growth
inhibition in children with liver and renal transplantation. J Clin
Endocrinol Metab 82:75–77, 1997
23. HOKKEN-KOELEGA A, MULDER P, DE JONG R, et al: Long-term ef-
fects of growth hormone treatment on growth and puberty in pa-
tients with chronic renal insufficiency. Pediatr Nephrol 14:701–6,
2000
24. HAEUSLER G, FRISCH H, WALDHOR T, Gotz M: Perspectives of longi-
tudinal growth in cystic fibrosis from birth to adult age. Eur J Pediatr
153:158–63, 1994
25. BALLINGER AB, SAVAGE MO, SANDERSON IR: Delayed puberty as-
sociated with inflammatory bowel disease. Pediatr Res 53:205–10,
2003
26. POZO J, ARGENTE J: Delayed puberty in chronic illness. Best Pract
Res Clin Endocrinol Metab 16:73–90, 2002
27. SCHAEFER F, GILLI G, SCHA¨RER K: Pubertal growth and final height in
chronic renal failure, in Growth and Endocrine Changes in Children
and Adolescents with Chronic Renal Failure, Pediatric and Adoles-
cent Endocrinology, edited by Scha¨rer K, Basel, Karger, 1989, pp
59–69
28. POTTER D, FEDUSKA N, MELZER J, et al: Twenty years of renal trans-
plantation in children. Pediatrics 77:465–470, 1986
29. HENNING P, TOMLINSON L, RIGDEN SP, et al: Long term outcome of
treatment of end stage renal failure. Arch Dis Child 63:35–40, 1988
30. HOKKEN-KOELEGA AC, VAN ZAAL MA, DE RIDDER MA, et al: Growth
after renal transplantation in prepubertal children: Impact of vari-
ous treatment modalities. Pediatr Res 35:367–371, 1994
31. OFFNER G, LATTA K, HOYER PF, et al: Kidney transplanted children
come of age. Kidney Int 55:1509–17, 1999
32. NINIK A, MCTAGGART SJ, GULATI S, et al: Factors influencing growth
and final adult height after renal transplantation. Pediatr Transplant
6:219–223, 2002
33. ENGLUND MS, TYDE´N G, WIKSTAD I, BERG UB: Growth impairment
at renal transplantation—A determinant of growth and final height.
Pediatr Transplant 7:192–199, 2003
34. FINE RN, STABLEIN D, COHEN AH, et al: Recombinant human growth
hormone post-renal transplantation in children: A randomized con-
trolled study of the NAPRTCS. Kidney Int 62:688–96, 2002
35. GUEST G, BERARD E, CROSNIER H, et al: Effects of growth hormone
in short children after renal transplantation. French Society of Pe-
diatric Nephrology. Pediatr Nephrol 12:437–46, 1998
36. KLAUS G, JUX C, FERNANDEZ P, et al: Suppression of growth
plate chondrocyte proliferation by corticosteroids. Pediatr Nephrol
14:612–5, 2000
